Lv1
45 积分 2021-01-24 加入
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study
1个月前
已完结
Radiotherapy combined with chemoimmunotherapy improves survival compared to chemoimmunotherapy alone as first-line treatment for oligometastatic esophageal squamous cell carcinoma
1个月前
已完结
The relationship between the treatment course and prognosis of oligometastasis after esophageal squamous cell carcinoma resection
1个月前
已完结
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview
1个月前
已完结
Using clinical and radiomic feature–based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation
1个月前
已完结
Cancer-associated fibroblasts affect breast cancer cell sensitivity to chemotherapeutic agents by regulating NRBP2
3个月前
已完结
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
3个月前
已完结
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
3个月前
已完结
Breaking barriers in Triple Negative Breast Cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs)
5个月前
已完结
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
5个月前
已完结
皖公网安备34019202002308
